AMRN
Price
$16.04
Change
+$3.43 (+27.22%)
Updated
Jun 24 closing price
Capitalization
357.53M
35 days until earnings call
ASND
Price
$179.10
Change
+$3.32 (+1.89%)
Updated
Jun 24 closing price
Capitalization
10.83B
76 days until earnings call
Interact to see
Advertisement

AMRN vs ASND

Header iconAMRN vs ASND Comparison
Open Charts AMRN vs ASNDBanner chart's image
Amarin
Price$16.04
Change+$3.43 (+27.22%)
Volume$1.16M
Capitalization357.53M
Ascendis Pharma A/S
Price$179.10
Change+$3.32 (+1.89%)
Volume$377.01K
Capitalization10.83B
AMRN vs ASND Comparison Chart in %
Loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRN vs. ASND commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Hold and ASND is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (AMRN: $12.60 vs. ASND: $175.78)
Brand notoriety: AMRN: Notable vs. ASND: Not notable
AMRN represents the Pharmaceuticals: Major, while ASND is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMRN: 68% vs. ASND: 63%
Market capitalization -- AMRN: $357.53M vs. ASND: $10.83B
AMRN [@Pharmaceuticals: Major] is valued at $357.53M. ASND’s [@Biotechnology] market capitalization is $10.83B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileASND’s FA Score has 0 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • ASND’s FA Score: 0 green, 5 red.
According to our system of comparison, both AMRN and ASND are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 3 TA indicator(s) are bullish while ASND’s TA Score has 5 bullish TA indicator(s).

  • AMRN’s TA Score: 3 bullish, 6 bearish.
  • ASND’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ASND is a better buy in the short-term than AMRN.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а -9.22% price change this week, while ASND (@Biotechnology) price change was -1.09% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.05%. For the same industry, the average monthly price growth was +4.74%, and the average quarterly price growth was +7.84%.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.91%. For the same industry, the average monthly price growth was +35.46%, and the average quarterly price growth was +17.29%.

Reported Earning Dates

AMRN is expected to report earnings on Jul 30, 2025.

ASND is expected to report earnings on Sep 09, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.05% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (+4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASND($10.8B) has a higher market cap than AMRN($358M). AMRN YTD gains are higher at: 29.897 vs. ASND (27.682). AMRN has higher annual earnings (EBITDA): -50.7M vs. ASND (-287.37M). ASND has more cash in the bank: 518M vs. AMRN (321M). AMRN has less debt than ASND: AMRN (8.74M) vs ASND (847M). ASND has higher revenues than AMRN: ASND (369M) vs AMRN (307M).
AMRNASNDAMRN / ASND
Capitalization358M10.8B3%
EBITDA-50.7M-287.37M18%
Gain YTD29.89727.682108%
P/E Ratio67.11N/A-
Revenue307M369M83%
Total Cash321M518M62%
Total Debt8.74M847M1%
FUNDAMENTALS RATINGS
AMRN vs ASND: Fundamental Ratings
AMRN
ASND
OUTLOOK RATING
1..100
1868
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
10076
SMR RATING
1..100
93100
PRICE GROWTH RATING
1..100
4041
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMRN's Valuation (87) in the Pharmaceuticals Other industry is in the same range as ASND (90) in the Biotechnology industry. This means that AMRN’s stock grew similarly to ASND’s over the last 12 months.

ASND's Profit vs Risk Rating (76) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that ASND’s stock grew similarly to AMRN’s over the last 12 months.

AMRN's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as ASND (100) in the Biotechnology industry. This means that AMRN’s stock grew similarly to ASND’s over the last 12 months.

AMRN's Price Growth Rating (40) in the Pharmaceuticals Other industry is in the same range as ASND (41) in the Biotechnology industry. This means that AMRN’s stock grew similarly to ASND’s over the last 12 months.

AMRN's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as ASND (100) in the Biotechnology industry. This means that AMRN’s stock grew similarly to ASND’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNASND
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
73%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 14 days ago
71%
Bullish Trend 28 days ago
71%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 8 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
67%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LPSN0.770.03
+4.56%
LivePerson
BWMN27.951.19
+4.45%
Bowman Consulting Group Ltd
KRNT18.970.80
+4.40%
Kornit Digital Ltd
SCL54.791.03
+1.92%
Stepan Co
PSO14.55-0.06
-0.41%
Pearson plc

AMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
+0.48%
KZR - AMRN
56%
Loosely correlated
-5.75%
CNTB - AMRN
55%
Loosely correlated
-5.34%
HRTX - AMRN
44%
Loosely correlated
+5.50%
MGNX - AMRN
44%
Loosely correlated
+0.76%
ALXO - AMRN
43%
Loosely correlated
-5.02%
More

ASND and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with NUVL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
-0.63%
NUVL - ASND
40%
Loosely correlated
+1.31%
ORMP - ASND
37%
Loosely correlated
-0.94%
AMRN - ASND
35%
Loosely correlated
+0.48%
AXON - ASND
34%
Loosely correlated
+0.76%
CASI - ASND
33%
Poorly correlated
-7.17%
More